INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL COMPARING HIGH-ROSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELT) WITH CARMUSTINE, ETOPOSIDE, CYTOSINE-ARABINOSIDE AND CYCLOPHOSPHAMIDE (BEAC) FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL (PBSC) INFUSION IN PATIENTS WITH RELAPSED HODGKINS-DISEASE (HD)

Authors
WEAVER CH SCHWARTZBERG LS UPTON S BIRCH R BUCKNER CD
Citation
Ch. Weaver et al., INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL COMPARING HIGH-ROSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELT) WITH CARMUSTINE, ETOPOSIDE, CYTOSINE-ARABINOSIDE AND CYCLOPHOSPHAMIDE (BEAC) FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL (PBSC) INFUSION IN PATIENTS WITH RELAPSED HODGKINS-DISEASE (HD), Blood, 88(10), 1996, pp. 3883-3883
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
2
Supplement
1
Pages
3883 - 3883
Database
ISI
SICI code
0006-4971(1996)88:10<3883:IAOARP>2.0.ZU;2-#